Insights
Filter posts
All Categories Clinical Strategy Regulatory Intellectual Property Health Economics
How the UK can accelerate radiology AI adoption
It’s no secret that the deployment of artificial intelligence in radiology is lagging behind expectations. Discover five ways AI adoption can be accelerated.
How to get reimbursement for your AI medical device before regulatory approval
Launching an AI medical device startup is an adventure but with escalating costs threatening to slow your progress, the path to your first sale appears steep. We look at how you can get reimbursement for your AI medical device before regulatory approval.
Hardian joins £20m Immersive Technology fund for mental health therapeutics
The new MindSet XR ecosystem for UK innovators working on immersive digital mental health therapeutics has been launched, including Hardian Health as a regulatory partner.
How To Conduct Due Diligence On SaMD And AIaMD Acquisitions
Expertise is needed to conduct thorough due diligence in the highly regulated and evidence-based healthcare sector. Hardian covers key clinical and regulatory points when conducting DD for investors, mergers, or acquisitions of an SaMD or AIaMD company.
How much documentation does my Software as a Medical Device regulatory submission really need?
Learn how to derive the documentation requirements for SaMD from the safety and risk class of the device and download a free cheat sheet to help you navigate regulatory submissions.
Critical success factors for a Software as a Medical Device regulatory submission
Through our extensive experience of regulatory submissions for SaMD the top five make-or-break success factors are Design Control, Requirements Management, Risk Management, Verification and Validation evidence, and Software Maintenance under Change Control.
Health Institution Exemptions for SaMD in Great Britain
Software as a Medical Device is getting easier to build. Because of this many hospitals and other healthcare providers are now developing their own software and AI medical devices in-house to serve their patients. Learn how health institution exemptions might apply to your in-house SaMD or AIaMD in Great Britain.
Early economic modelling of AI as medical device - answering the ‘why’
In recent months The National Institute of Health Care and Excellence (NICE) have released several key guidances on the use of AI in the UK. The recommendations made in these highlight the current position that many companies with AI technologies as a medical device (AIaMD) find themselves in. That is, a need to demonstrate why health systems need them. We take a look at why this is so important.
The Role of a Strong Market Strategy for SaMD
After investing significant amounts of time, capital, and resources into your healthcare innovation, the crucial next phase is to secure its market success. In this article, we take a look at the building blocks of a strong market strategy.
How to get wearables and companion apps regulatory approved
Wearable devices, such as bracelets, patches, smartwatches, and virtual reality goggles are taking center stage in the digital healthcare revolution. In this article we take a look at how wearables and associated apps are regulated in the EU.
How do you safeguard success in the Software as Medical Device industry? An expert’s guide to intellectual property
In the medical device industry, the role of intellectual property cannot be overstated. Whether you're a founder of a medical device company or a professional in the field, understanding and protecting your IP is critical for the growth and sustainability of your business.
AI, Innovation and Regulation: Solving Healthtech Puzzles at the Hardian Healthtech Summit
We hosted our second annual Healthtech Summit, bringing together a diverse community of healthtech leaders to share their stories and learn from each other.
How long does an FDA 510(k) submission for SaMD and AI actually take?
Advertised as a 90 day process, we analysed the data to find out how long it really takes for manufacturers to receive their 510(k) clearance.
Making the Unexpected Expected: A Founders’ Guide to Unannounced Audits
If you currently have a UKCA or CE marked medical device on the market you should anticipate unannounced audits to be conducted on your organisation. We explain what they are and how you should be preparing for them.
What does the EU AI Act mean for the future of AI regulation?
From ChatGPT to deepfakes, AI development is rapidly progressing. In reaction to the current landscape of AI the European Commission is setting a standard with its new approach to AI regulation through the introduction of the EU Artificial Intelligence Act.
Taking the pain out of implementation for AI medical devices
The market launch of your AI product is a huge achievement. It is the point from which you should finally begin to enjoy returns on years of personal and financial investment. We take a look at best practice implementation strategy to ensure success.
Building a Go-To-Market Strategy with AlphaBiomics
We supported AlphaBiomics' co-founder and CEO, Anthony Williamson, to develop a go-to-market (GTM) strategy to help them bring precision medicine to chronic inflammatory diseases.
The ISO standards you need to know for SaMD and where to find them.
ISO standards are designed to help businesses ensure that their products and services meet a certain level of quality, safety, and effectiveness. Healthtech has its own standards that organisations may need to conform to, here are the ones that you need to know and where you can find them.